You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse/progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Medulloblastoma, Childhood, Recurrent
  • AloCELYVIR
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús
Sep 29, 2022

Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

Recruiting
  • Multiple Myeloma in Relapse
  • Daratumumab/Lenalidomide/Dexamethasone for 24 months
  • Daratumumab/Lenalidomide/Dexamethasone until progression
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Jun 10, 2022

Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate

Active, not recruiting
  • Adenocarcinoma of Prostate
  • Progression of Prostate Cancer
  • Villejuif, France
    Institut Gustave Roussy
Oct 5, 2021

Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)

Recruiting
  • Multiple Myeloma in Relapse
  • +5 more
  • London, Ontario, Canada
    London Health Sciences Centre
Oct 3, 2022

Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

Active, not recruiting
  • Epithelial Ovarian Cancer
  • MK-1775 and carboplatin
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Dec 21, 2021

Diffuse Large B Cell Lymphoma After First Relapse/Progression

Unknown status
  • Lymphoma, Large B-Cell, Diffuse
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Mar 16, 2020

    Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)

    Unknown status
    • Wilms Tumor
    • +2 more
    • P53, Ki67 and Cyclin A IHC.
    • Mansoura, Dakahlia, Egypt
      Mansoura Urology and Nephrology Center. Faculty of Medicine, Man
    Feb 16, 2021

    Diagnosis of ON With or Without MS or NMOSD

    Enrolling by invitation
    • Multiple Sclerosis
    • +4 more
    • Reflex (Brightlamp Inc., Purdue University)
    • Lexington, Kentucky
      University of Kentucky
    Apr 27, 2021

    Rheumatoid Arthritis Trial in Paris (Tocilizumab, Abatacept, Decrease Tocilizumab, Abatacept)

    Completed
    • Rheumatoid Arthritis
    • Tocilizumab, Abatacept
    • Decrease Tocilizumab, Abatacept
    • Paris, France
      CHU Pitié Salpêtrière
    Jan 24, 2021

    Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

    Completed
    • DLBCL
    • Old Age; Debility
      • Homburg, Saarland, Germany
        Saarland University Medical Center
      Nov 20, 2023

      Glioblastoma Trial in Canada (PX-866)

      Completed
      Has Results
      • Glioblastoma
      • Calgary, Alberta, Canada
      • +6 more
      May 7, 2020

      FDG-PET in Patients With FL at Time of Relapse/Progression

      Completed
      • Follicular Lymphoma
      • Metabolic activity measured by FDG-PET
      • Trani, BT, Italy
      • +26 more
      Feb 5, 2020

      Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

      Recruiting
      • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
        • Milan, Italy
          Ospedale San Raffaele
        Aug 29, 2023

        Lymphoma, Follicular Trial (Mosunetuzumab)

        Not yet recruiting
        • Lymphoma, Follicular
        • (no location specified)
        May 8, 2023

        Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +4 more
          • (no location specified)
          Nov 1, 2023

          Elevated Factor VIII Related Labs asBiomarker for Incomplete

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • blood tests drawn days 1, 8, 22 and 90 of the study
          • (no location specified)
          Jun 22, 2023

          NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

          Suspended
          • NHL
          • +3 more
          • Minneapolis, Minnesota
          • +1 more
          Jan 31, 2023

          Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

          Recruiting
          • Chronic Graft Versus Host Disease
          • Duarte, California
            City of Hope Site Number : 8400001
          Nov 23, 2023

          Glioblastoma Trial in Zhengzhou (Individualized intervention based on genomic alterations)

          Enrolling by invitation
          • Glioblastoma
          • Individualized intervention based on genomic alterations
          • Zhengzhou, Henan, China
            Henan Provincial People's Hospital
          Sep 10, 2022

          Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

          Recruiting
          • Diffuse Large B-cell Lymphoma Recurrent
          • Diffuse Large B Cell Lymphoma Refractory
          • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
          • Hangzhou, Zhejiang, China
            Zhejiang Cancer Hospital
          Oct 12, 2023

          Multiple Sclerosis Trial in Brussels (Visual Evoked Potential (VEP), Somatosensory evoked potential (SSEP), Transcranial

          Recruiting
          • Multiple Sclerosis
          • Visual Evoked Potential (VEP)
          • +5 more
          • Brussels, Belgium
            CHU Brugmann
          Jul 4, 2023

          MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

          Recruiting
          • Myelodysplastic Syndromes
          • Saint Louis, Missouri
            Washington University School of Medicine
          Jan 18, 2023

          Myeloid Leukemia, MDS Trial (IFN-?)

          Not yet recruiting
          • Myeloid Leukemia
          • Myelodysplastic Syndromes
          • (no location specified)
          Nov 15, 2023

          Lymphoma, Non-Hodgkin Trial in Worldwide (Nivolumab, Rituximab, Gemcitabine)

          Recruiting
          • Lymphoma, Non-Hodgkin
          • Feldkirch, Austria
          • +78 more
          Nov 18, 2021